8-K item 3.01
Exchange deficiency notices
Open Nasdaq and NYSE listing deficiency notices and their cure deadlines as stated in the filing.
Open notices by deadline 3
| Company | Rule | Notice | Cure by | Filing |
|---|---|---|---|---|
| DocGo | Stock under $1Nasdaq rule 5550(a)(2) | Jul 28, 2026 | Jan 25, 2027 | 8-K item 3.01 |
| BioRestorative Therapies | Late filingNasdaq rule 5250(c)(1) | Aug 21, 2026 | Feb 16, 2027 | 8-K item 3.01 |
| Cryo Cell International | Reason not stated | May 6, 2026 | Sep 9, 2027 | 8-K item 3.01 |
Data through Nov 2, 2026, the newest 8-K item 3.01 SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. Not investment advice. Not affiliated with the U.S. SEC. Listing deadlines on the calendar · All screens